Baylor WRHR Program
贝勒 WRHR 计划
基本信息
- 批准号:7058266
- 负责人:
- 金额:$ 38.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-27 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The Baylor WRHR Center Program will greatly enhance academic career development for the Ob/Gyn physician investigator pursuing molecular medicine. On behalf of Baylor College of Medicine (BCM) Department of Obstetrics and Gynecology and University of Texas (UT) M.D. Anderson Cancer Center (M.DAC.C) Department of Gynecologic Oncology, this WRHR proposal is submitted. Baylor/M.D. Anderson WRHR is ideally placed, with strong core resources at two leading institutions and an Advisory Committee from both institutions (Principal Investigator Joe Leigh Simpson, Program Director Colin Bishop; M.D. Anderson Primary Investigator David Gershenson; Baylor: Arthur Beaudet, Bert O'Malley, Martin Matzuk, Larry Chan, Huda Zoghbi, Dennis Bier, Baruch Brody; M.D. Anderson: Michele Pollen, Thomas Burke). Primary (Research) Mentors with world-class molecular programs have been identified using set criteria. Of the 22, 6 are in Ob/Gyn at Baylor, 3 in Gynecologic Oncology at M.D. Anderson, and 13 in other Baylor Departments. Most research mentors already collaborate actively with Baylor Ob/Gyn.
Baylor and M.D. Anderson have a strong internal pool of Ob/Gyn candidates and proven ability to recruit outside K-12 Scholars, as judged by the highly successful Baylor BIRCWH Program. M.D. Anderson has the nation's largest Gynecologic Oncology Training Program, a four-year program that includes 2 years of laboratory research. Baylor/M.D. Anderson WRHR will also aggressively recruit candidates outside Baylor and M.D. Anderson, especially minority candidates. Selection steps include candidates visiting Baylor and M.D. Anderson, selecting a mentor and with the mentor, prepare a research and educational plan. Scholars will be selected by the Advisory Committee using defined criteria.
Each educational plan will include not only developing laboratory investigative expertise under one of the 22 Research Mentors, but a) 5 required courses/seminars (Fundamentals of Clinical Investigation: Cellular and Molecular Biology of Disease: WRHR Molecular Medicine Seminar: WRHR/BIRCWH Seminars in Women's Health: Ethics Symposium), b) additional courses as needed, c) WRHR research conferences, at which Scholars have their work critiqued, d) yearly WRHR Distinguished Speaker, and e) once yearly meetings of all WRHR Scholars in the Southwest to leverage networking. Regularly scheduled evaluations assure sequential benchmarks of success: 1) peer review abstracts by early year -02, 2) publications in journals of defined impact factors, 3) year -03 RO3 or private foundation support, culminating in 4) RO1 submission and eventual support. A Secondary (Clinical/Academic) Mentor (e.g., Ob/Gyn Division Director) will provide WRHR Scholars clinical perspective and introduce them into leadership roles in their subspecialty. Missions of Baylor WRHR and Baylor BIRCWH are distinct. Fifth in NIH funding among medical schools and renowned for its genetic resources (faculty and facilities), Baylor with cooperation of M.D. Anderson is fully capable of training both BIRCWH and WRHR Scholars.
描述(由申请人提供):贝勒WRHR中心计划将大大提高OB/Gyn医师研究人员追求分子医学的学术职业发展。我代表贝勒医学院(Baylor College of Medicine)妇产科系和德克萨斯大学(University of Texas)医学博士安德森癌症中心(M. DAC. C)妇科肿瘤科,本WRHR提案已提交。贝勒/医学博士安德森WRHR是理想的位置,强大的核心资源,在两个领先的机构和咨询委员会从两个机构(首席研究员乔利辛普森,项目主任科林主教;医学博士。安德森主要研究者大卫格申森;贝勒:亚瑟博德特、伯特奥马利、马丁马祖克、拉里陈、胡达佐格比、丹尼斯比尔、巴鲁克布罗迪;医学博士安德森:米歇尔花粉,托马斯伯克)。主要(研究)导师与世界一流的分子程序已确定使用设置标准。在这22人中,6人在贝勒妇产科,3人在医学博士妇科肿瘤科。安德森和其他贝勒部门的13人。 大多数研究导师已经与贝勒妇产科积极合作。
贝勒和医学博士根据非常成功的贝勒BIRCWH计划的判断,安德森拥有强大的内部Ob/Gyn候选人库,并且拥有招募外部K-12学者的能力。M.D.安德森拥有全国最大的妇科肿瘤培训计划,一个为期四年的计划,包括2年的实验室研究。贝勒/医学博士安德森WRHR还将积极招募贝勒和医学博士以外的候选人。安德森,尤其是少数族裔候选人。选拔步骤包括候选人访问贝勒和医学博士。安德森,选择一个导师和导师,准备一个研究和教育计划。学者将由咨询委员会使用定义的标准选择。
每个教育计划不仅包括在22名研究导师之一的指导下发展实验室调查专业知识,还包括a)5门必修课程/研讨会(临床研究基础:疾病的细胞和分子生物学:WRHR分子医学研讨会:WRHR/BIRCWH妇女健康研讨会:伦理研讨会),B)根据需要增加课程,c)WRHR研究会议,学者们在会上对他们的工作进行批评,d)每年的WRHR杰出演讲人,和e)西南地区所有WRHR学者的年度会议,以利用网络。定期安排的评估确保了成功的连续基准:1)2002年初的同行评审摘要,2)在期刊上发表定义的影响因素,3)2003年RO 3或私人基金会的支持,最终达到4)RO 1提交和最终支持。二级(临床/学术)导师(例如,妇产科主任)将提供WRHR学者的临床观点,并介绍他们在其子专业的领导角色。贝勒WRHR和贝勒BIRCWH的使命是不同的。在NIH的资助中排名第五,并以其遗传资源(教师和设施)而闻名,贝勒大学与医学博士合作。安德森完全有能力培训BIRCWH和WRHR学者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOE LEIGH SIMPSON其他文献
JOE LEIGH SIMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOE LEIGH SIMPSON', 18)}}的其他基金
CONFERENCE--ISOLATED FETAL CELLS IN MATERNAL BLOOD
会议——母血中分离的胎儿细胞
- 批准号:
3435428 - 财政年份:1993
- 资助金额:
$ 38.66万 - 项目类别:
COMPARISON OF CHORION VILLUS SAMPLING AND AMNIOCENTESIS
绒毛膜绒毛取样与羊膜穿刺术的比较
- 批准号:
3552573 - 财政年份:1986
- 资助金额:
$ 38.66万 - 项目类别:
COMPARISON OF CHORION VILLUS SAMPLING AND AMNIOCENTESIS
绒毛膜绒毛取样与羊膜穿刺术的比较
- 批准号:
3552577 - 财政年份:1986
- 资助金额:
$ 38.66万 - 项目类别: